Sign in

CIK 0001739174 · Non-accelerated filer<br>Smaller reporting company

Tessera Defense & Homeland Security Inc.

Sign in to watch
Ticker
HLSQ
Exchange
NYSE
Industry
Services-Prepackaged Software
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823364020
Phone
972 545610935
Business address
850 NEW BURTON ROAD, SUITE 201, DOVER, DE, 19904
Former names
BiomX Inc., Chardan Healthcare Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-17 Yeganeh Reuven Director Conversion +530,000 $2.00 $1.1M 530,000
2026-03-17 Yeganeh Reuven Director Sale −530,000 $5.00 $2.6M 0
2026-03-17 Yeganeh Reuven Director Conversion · Series Y Convertible Preferred Stock −1,060 0
2026-03-16 Yeganeh Reuven Director Conversion +450,000 $2.00 $900K 450,000
2026-03-16 Yeganeh Reuven Director Sale −450,000 $5.00 $2.3M 0
2026-03-16 Yeganeh Reuven Director Conversion · Series Y Convertible Preferred Stock −900 1,060
2026-03-16 Yeganeh Reuven Director Sale · Common Stock Purchase Warrants −1,300,000 $5.00 $6.5M 2,000,000
2026-03-16 Yeganeh Reuven Director Sale · Common Stock Purchase Warrants −2,000,000 $5.24 $10.5M 1,700,000
2026-03-16 Yeganeh Reuven Director Sale · Common Stock Purchase Warrants −1,700,000 $4.76 $8.1M 0
2026-03-13 Yeganeh Reuven Director Conversion +370,000 $2.00 $740K 370,000
2026-03-13 Yeganeh Reuven Director Sale −370,000 $5.00 $1.9M 0
2026-03-13 Yeganeh Reuven Director Conversion · Series Y Convertible Preferred Stock −740 1,960
2026-03-12 Yeganeh Reuven Director Sale −300,000 $5.00 $1.5M 0
2026-03-12 Yeganeh Reuven Director Conversion · Series Y Convertible Preferred Stock −600 2,700
2026-03-11 Yeganeh Reuven Director Conversion +300,000 $2.00 $600K 30,000
2025-04-21 Flynn James E Director Grant or award · Warrants +1,611,864 1,611,864
2025-04-21 Flynn James E Director Grant or award · Warrants +1,611,864 1,611,864
2025-04-14 Merril Gregory Louis Director Grant or award · Common Stock Options - right to Buy +17,600 17,600
2025-04-14 Bassan Merav Chief Development Officer Grant or award +79,597 79,597
2025-04-14 Bassan Merav Chief Development Officer Grant or award · Common Stock Options - right to Buy +95,000 95,000

Page 1 of 12 · 240 trades